Herkenne, S. (01 December 2023). 1. Mitochondria control the communication of cancer cells with the tumor microenvironment [Paper presentation]. Mitochondrie apoptosis and cancer meeting, coimbra, Portugal.  Peer reviewed |
Herkenne, S. (02 October 2023). 2. MDVs control endosomal maturation [Paper presentation]. EMBO contacts sites meeting. Peer reviewed |
  | Marchesan, E., Alice Nardin, Sofia Mauri, Simone Di Paola, Monica Chinellato, Sophia von Stockum, Joy Chakraborty, Herkenne, S., Valentina Basso, Emilie Schrepfer, Oriano Marin, Laura Cendron, Diego L. Medina, Luca Scorrano, & Elena Ziviani. (2023). Activation of Ca2+ phosphatase Calcineurin regulates Parkin translocation to mitochondria and mitophagy. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/304655. |
Herkenne, S. (06 September 2022). Mitochondria: new regulator of endosomal trafficking [Paper presentation]. GIGA day. Peer reviewed |
Herkenne, S. (24 June 2022). Mitochondria: new regulator of endosomal pathway [Paper presentation]. talk IBM. Peer reviewed |
 | NJOCK, M.-S.* , O'Grady, T.* , Nivelles, O., Lion, M., Jacques, S., Cambier, M., Herkenne, S., Muller, F., Christian, A., REMACLE, C., GUIOT, J., Rahmouni, S., Dequiedt, F.* , & Struman, I.*. (June 2022). Endothelial extracellular vesicles promote tumour growth by tumour-associated macrophage reprogramming. Journal of Extracellular Vesicles, 11 (6), 12228. doi:10.1002/jev2.12228 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Herkenne, S. (08 April 2022). Regulation of endosomal trafficking by mitochondrial dynamic and mitochondria-derived vesicles [Paper presentation]. Séminaire TELEVIE. Peer reviewed |
Herkenne, S. (17 March 2022). Mitochondrial dynamic regulates miRNA expression in breast cancer [Paper presentation]. Meeting NARILIS. Peer reviewed |
 | Zamberlan, M.* , Boeckx, A.* , Muller, F., Vinelli, F., Ek, O., Vianello, C., Coart, E., Shibata, K., Christian, A., Grespi, F., Giacomello, M., Struman, I., Scorrano, L.* , & Herkenne, S.*. (12 March 2022). Inhibition of the mitochondrial protein Opa1 curtails breast cancer growth. Journal of Experimental and Clinical Cancer Research, 41 (1), 95. doi:10.1186/s13046-022-02304-6 Peer reviewed* These authors have contributed equally to this work. |
 | Fontaine, M., Herkenne, S., Ek, O., Paquot, A., Boeckx, A., Paques, C., Nivelles, O., Thiry, M., & Struman, I. (2022). Extracellular Vesicles Mediate Communication between Endothelial and Vascular Smooth Muscle Cells. International Journal of Molecular Sciences, 23 (1). doi:10.3390/ijms23010331 Peer Reviewed verified by ORBi |
  | Bean, C., Audano, A., Varanita, T., Favaretto, F., Medaglia, M., Gerdol, M., Pernas, L., Giacomello, M., Herkenne, S., Muniandy, M., Heinonen, S., Milan, G., Pallavicini, A., Pietiläinen, K., Vettor, R., Mitro, N., & Scorrano, L. (2021). The mitochondrial protein Opa1 promotes adipocyte browning that is dependent on urea cycle metabolites. Nature Metabolism. doi:10.1038/s42255-021-00497-2 Peer reviewed |
Herkenne, S. (17 November 2021). the mitochondrial fission factor dynamin related protein 1 (DRP1) limits angiogenesis by interfering with VEGFR2 trafficking [Paper presentation]. Société française d'angiogenèse. Peer reviewed |
 | Herkenne, S., & Scorrano, L. (13 November 2020). OPA1, a new mitochondrial target in cancer therapy. Aging, 12, 20931-20933. doi:10.18632/aging.104207 Peer Reviewed verified by ORBi |
Herkenne, S. (2020). mitochondria and vesicles link [Paper presentation]. Présentation young investigator. |
 | Angioni, R., Liboni, C., Herkenne, S., Sanchez-Rodriguez, R., Borile, G., Marcuzzi, E., Cali, B., Muraca, M., & Viola, A. (2020). CD73 + extracellular vesicles inhibit angiogenesis through adenosine A 2B receptor signalling. Journal of Extracellular Vesicles. doi:10.1080/20013078.2020.1757900 Peer Reviewed verified by ORBi |
 | Herkenne, S., ek, O., Zamberlan, M., Pellatiero, A., Chergova, M., chivite, L., Novotna, E., Rigoni, G., Fonseca, T., samardzic, D., Agnellini, A., Bean, C., Di Benedetto, G., Tiso, N., Argenton, F., viola, A., Sorianno, M., Giacommello, M., Ziviani, E., ... Scorrano, L. (2020). Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1. Cell Metabolism. doi:10.1016/j.cmet.2020.04.007 Peer Reviewed verified by ORBi |
 | Zaninello, M., Palikaras, K., Naon, D., Iwata, K., Herkenne, S., Quintana-Cabrera, R., Semenzato, M., Grespi, F., Ross-Cisneros, F., Carelli, V., Sadun, A., Tavernarakis, N., & Scorrano, L. (2020). Inhibition of autophagy curtails visual loss in a model of autosomal dominant optic atrophy. Nature Communications. doi:10.1038/s41467-020-17821-1 Peer Reviewed verified by ORBi |
Herkenne, S. (2020). Mitochondria and EVs [Paper presentation]. Young PI selection CECAD, Cologne, Germany. Peer reviewed |
Herkenne, S. (2019). Developmental and tumor angiogenesis requires changes in endothelial cell mitochondria-shaping protein OPA1 [Paper presentation]. 6th Biannual Meeting on Mitochondria Apoptosis & Cancer, Prague, CSK. Peer reviewed |
Herkenne, S., & Herkenne, S. (2019). The mitochondrial fission factor Dynamin-related protein 1 (Drp1) limits VEGF/VEGFR2 endocytic trafficking and angiogenesis [Paper presentation]. meeting in Padova. Peer reviewed |
Herkenne, S. (2019). Developmental and tumor angiogenesis requires changes in endothelial cell mitochondrial shape [Paper presentation]. 3rd retreat of the Department of Biology, University of Padova, Padova, Italy. Peer reviewed |
Herkenne, S. (2019). 3. The mitochondrial fission factor Dynamin Related Protein 1 limits VEGF/VEGFR2 endocytic trafficking and angiogenesis [Paper presentation]. 3rd ESM-EVBO Conference, Maastricht, Netherlands. Peer reviewed |
Herkenne, S. (15 October 2018). The mitochondria shaping protein Optic Atrophy 1 (OPA1) controls angiogenesis [Paper presentation]. Société française d'angiogenèse. Peer reviewed |
 | Loubiere, C., Clavel, S., Gilleron, J., Harisseh, R., Fauconnier, J., Ben-Sahra, I., Kaminski, L., Laurent, K., Herkenne, S., Lacas-Gervais, S., Ambrosetti, D., Alcor, D., Rocchi, S., Cormont, M., Michiels, J., Mari, B., mazure, N., scorrano, L., lacampagne, A., ... Bost, F. (2017). The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells. Scientific Reports. doi:10.1038/s41598-017-05052-2 Peer Reviewed verified by ORBi |
 | Naon, D., Zaninello, M., Giacommello, M., Varanita, T., Grespi, F., Lakshminaranayan, S., Serafini, A., Semenzato, M., Herkenne, S., Hernández-Alvarez, Zorzano, A., De Stefani, D., Dworn, G., & Scorrano, L. (2017). Reply to Filadi et al.: Does Mitofusin 2 tether or separate endoplasmic reticulum and mitochondria? Proceedings of the National Academy of Sciences of the United States of America. Peer Reviewed verified by ORBi |
Herkenne, S. (2016). The mitochondrial shaping protein Optic Atrophy 1 (OPA1) controls angiogenesis, lymphangiogenesis and tumor growth [Paper presentation]. Mito Insbruck-Padova, Insbruck, Austria. Peer reviewed |
Herkenne, S. (2016). The mitochondrial shaping protein Optic Atrophy 1 (OPA1) controls angiogenesis and tumor growth [Paper presentation]. pADOVA-iNBRUCK MEETING. Peer reviewed |
 | naon, D., zaninello, M., giacomello, M., varanita, T., grespi, F., Lakshminaranayan, S., Serafini, A., semenzato, M., Herkenne, S., hernadez-alvarez, M., zorzano, A., De stefani, D., Dworn, G., & Scorrano, L. (2016). Critical reappraisal confirms that Mitofusin 2 is anendoplasmic reticulum–mitochondria tether. Proceedings of the National Academy of Sciences of the United States of America. doi:10.1073/pnas.1606786113 Peer Reviewed verified by ORBi |
 | Herkenne, S., Paques, C., Nivelles, O., Lion, M., BAJOU, K., Pollenus, T., Fontaine, M., Carmeliet, P., Martial, J., Nguyen, N.-Q.-N., & Struman, I. (2015). The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis. Science Signaling, 8 (403), 117. doi:10.1126/scisignal.aaa2403 Peer Reviewed verified by ORBi |
Herkenne, S. (2015). The mitochondria shaping protein Optic Atrophy 1 (OPA1) controls angiogenesis [Paper presentation]. Société française d'angiogenèse, Paris, France. |
Herkenne, S. (2015). The mitochondria shaping protein Optic Atrophy 1 (OPA1) controls angiogenesis [Paper presentation]. 6ème congrès de la SFA à Paris. Peer reviewed |
Herkenne, S. (21 October 2014). Involvement of mitochondrial dynmics in the regulation of angiogenesis [Paper presentation]. EMBO interview. Peer reviewed |
Paques, C., Herkenne, S., Pollenus, T., & Struman, I. (May 2014). Growth Factors-Induced Angiogenesis Requires uPAR on Endothelial Cells [Poster presentation]. Giga Cancer Day, Liège, Belgium. |
 | Bajou, K.* , Herkenne, S.* , Thijssen, V. L., D'Amico, S., Nguyen, N.-Q.-N., Bouche, A., Tabruyn, S., Srahna, M., Carabin, J.-Y., Nivelles, O., Paques, C., Cornelissen, Y., Lion, M., Noël, A., Gils, A., Vinckier, S., Declerck, P. J., Griffioen, A. W., Dewerchin, M., ... Struman, I. (2014). PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin. Nature Medicine, (7), 741. doi:10.1038/nm.3552 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Herkenne, S. (2013). Détermination du rôle de l'interactome PAI-1/uPA/uPAR dans l'angiogenèse [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/153730 |
Paques, C., Herkenne, S., & Struman, I. (2013). Tumor-Induced Angiogenesis Requires uPAR on Endothelial Cells [Poster presentation]. Giga Cancer Day. |
Herkenne, S., Bajou, K., Nguyen, N.-Q.-N., Martial, J., & Struman, I. (19 May 2012). Implication of the PAI-1/uPA/uPAR signalosome in the antiangiogenic action of 16K prolactin [Poster presentation]. GIGA-Cancer Day, Liège, Belgium. |
Herkenne, S., Dalla Valle, A., Bajou, K., Nguyen, N.-Q.-N., Martial, J., & Struman, I. (April 2012). Implication of the PAI-1/uPA/uPAR complex in the antiangiogenic action of 16K prolactin [Poster presentation]. Biomedica, Liège, Belgium. |
Herkenne, S., Dalla Valle, A., Bajou, K., Nguyen, N.-Q.-N., Martial, J., & Struman, I. (2012). Implication of the PAI-1/uPA/uPAR complex in the antiangiogenic action of 16K hPRL [Poster presentation]. Keystone symposia on Angiogenesis: Advances in Basic Science and Therapeutic Applications, Snowbird, United States - Utah. |
 | Nguyen, N.-Q.-N., Castermans, K., Berndt, S., Herkenne, S., Tabruyn, S., Blacher, S., Lion, M., Noël, A., Martial, J., & Struman, I. (07 November 2011). The Antiangiogenic 16K Prolactin Impairs Functional Tumor Neovascularization by Inhibiting Vessel Maturation. PLoS ONE, 6 (11), 27318-27318. doi:10.1371/journal.pone.0027318 Peer Reviewed verified by ORBi |
Nguyen, N.-Q.-N., Castermans, K., Berndt, S., Herkenne, S., Tabruyn, S., Blacher, S., Lion, M., Noël, A., Martial, J., & Struman, I. (May 2011). The antiangiogenic 16K prolactin disturbs functional tumor neovascularization by affecting vessel maturation [Poster presentation]. 4th International Meeting on Angiogenesis, Amsterdam, Netherlands. |
Herkenne, S., Bajou, K., D'Amico, S., Nguyen, N.-Q.-N., Martial, J., & Struman, I. (2011). Implication of the PAI-1/uPA/uPAR complex in the effects of the antiangiogenic factor 16K hPRL [Poster presentation]. Giga cancer day, Liège, Belgium. |
Bajou, K., Herkenne, S., Thijssen, V. L., D'Amico, S., Srahna, M., Carabin, J.-Y., Gils, A., Declerck, P. J., Griffioen, A. W., Martial, J., & Struman, I. (January 2011). PAI-1 mediates antiangiogenic and fibrinolytic actions of prolactin/growth hormone 16-14K fragments [Poster presentation]. Giga-Day Symposia, Liège, Belgium. |
 | Kinet, V., Castermans, K., Herkenne, S., Maillard, C., Blacher, S., Lion, M., Noël, A., Martial, J., & Struman, I. (2011). The Angiostatic Protein 16K Human Prolactin Significantly Prevents Tumor-Induced Lymphangiogenesis by Affecting Lymphatic Endothelial Cells. Endocrinology. doi:10.1210/en.2011-1081 Peer Reviewed verified by ORBi |
Herkenne, S., Bajou, K., D'Amico, S., Martial, J., & Struman, I. (21 May 2010). Study of the signalling pathway of 16K PRL and 14K GH for mediate their anti-angiogenic effect [Poster presentation]. GIGA-Cancer Day, Liège, Belgium. |
